🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

14+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 14 of 14 recruiting trials for “Chondrosarcoma”

RecruitingNCT07315542 ↗

Diagnostic and Therapeutic Targets in Cartilaginous Tumours

👨‍⚕️ Tomáš Tomáš, Assoc.Prof., M.D., Ph.D., Faculty of Medicine, Masaryk University, Brno, 60200, Czechia📍 1 site📅 Started May 2025View details ↗
EARLY_Phase 1RecruitingNCT06645808 ↗

PET-imaging of Two Vartumabs in Patients With Solid Tumors

👨‍⚕️ Gooitzen van Dam, MD, PhD, TRACER Europe B.V.📍 1 site📅 Started Dec 2024View details ↗
Phase 3RecruitingNCT06127407 ↗

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

🏥 Servier Bio-Innovation LLC📍 114 sites📅 Started Jul 2024View details ↗
RecruitingNCT06486506 ↗

Proximal Femur Reconstruction Following Resection of Primary Bone Tumors: Analysis of the Clinical and Radiographic Results

🏥 Costantino Errani📍 1 site📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT06176989 ↗

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

👨‍⚕️ Charalampos Floudas, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Mar 2024View details ↗
NARecruitingNCT06387485 ↗

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

🏥 Ricoh USA, Inc.📍 3 sites📅 Started Mar 2024View details ↗
NARecruitingNCT05861245 ↗

Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base

🏥 Quironsalud📍 1 site📅 Started May 2023View details ↗
Phase 2RecruitingNCT05193188 ↗

A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma

👨‍⚕️ Binghao Li, Medical PhD, Second Affiliated Hospital of Zhejiang University School of Medicine📍 1 site📅 Started Feb 2023View details ↗
RecruitingNCT05779670 ↗

Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery

👨‍⚕️ alida abbruzzese, ufficio ricerca professioni sanitarie📍 1 site📅 Started Jan 2023View details ↗
RecruitingNCT05033288 ↗

Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone

👨‍⚕️ Bradford S. Hoppe, MD, MPH, Mayo Clinic📍 3 sites📅 Started Jan 2022View details ↗
Phase 2RecruitingNCT04305548 ↗

Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma

👨‍⚕️ Silvia Stacchiotti, MD, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano📍 7 sites📅 Started Sep 2021View details ↗
Phase 2RecruitingNCT04673942 ↗

A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors

👨‍⚕️ Bryan Oronsky, MD PhD, EpicentRx, Inc.📍 6 sites📅 Started Mar 2021View details ↗
Phase 2RecruitingNCT04040205 ↗

Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

👨‍⚕️ John Charlson, MD, Medical College of Wisconsin📍 4 sites📅 Started Oct 2019View details ↗
RecruitingNCT03442465 ↗

Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas

👨‍⚕️ Daniel Prince, MD, Memorial Sloan Kettering Cancer Center📍 3 sites📅 Started Feb 2018View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →